Answer
Aspartate aminotransferase (AST), alanine aminotransferase (ALT) and bilirubin should be monitored before starting atezolizumab, periodically during treatment and as indicated by clinical evaluation.
Sources for this answer
- Tecentriq 840 mg and 1,200 mg concentrate for solution for infusionRoche Products Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 41Document updated
Sources checked